Connect with us

Company News

Stilla Technologies launches its brand-new line of naica PCR reagents

Stilla Technologies, a leading European provider of pioneering solutions for high–precision genetic analyses, just introduced a dedicated digital PCR MIX reagent line for optimal performance with Crystal Digital PCR: the naica multiplex PCR MIX and the naica PCR MIX. These new reagents are ready-to-use solutions optimized for performance and robustness for digital PCR applications. The reagents are available at both 5x and 10x concentrations, making these PCR mastermixes the highest concentrated for digital PCR applications. These highly concentrated PCR mastermixes maximize the sensitivity of customers assay by increasing sample uptake and by lowering the assay’s limit of detection.

Stilla Technologies also announced its partnership with ID-Solutions1 to commercialize directly the IDENTIFY kit line, thereby providing a range of ready-to-use oncology kits for detecting multiplexed mutation panels using the naica® system. With this partnership, the two companies aim to offer standard operating procedures and diagnostic tools to meet the urgent clinical needs for highly sensitive and easy-to-use workflows in oncological applications.

“We are very excited to add these new product lines to our portfolio:  the naica PCR MIX is the cornerstone of our strategy towards full solutions for digital PCR on the naica system. It’s built for performance and enables robust application development on our platform. The IDENTIFY kit line is the first of such full solutions for oncology applications, demonstrating the power of our multiplexing approach to digital PCR,” said Rémi Dangla, Cofounder and CEO of Stilla Technologies. – PR Newswire

Copyright © 2024 Medical Buyer

error: Content is protected !!